Skip to main content
main-content

15-02-2020 | ASCO GU 2020 | Conference coverage | Video

Researcher comment: The BLASST-1 trial

Shilpa Gupta gives the top-line results of their trial investigating the addition of nivolumab to neoadjuvant cisplatin-based chemotherapy in muscle-invasive bladder cancer. She also discusses the neoadjuvant NEO-BLADE study presented at the conference and speculates on the reasons for the differing results (3:16).

Read transcript

ASCO GU 2020 conference hub

Image Credits